Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity (Unaudited)

v3.21.1
Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (loss)
Total
Balances at Aug. 31, 2019 $ 3,354 $ 10,278,421 $ (4,810,756) $ (9,806) $ 5,461,213
Balances (in shares) at Aug. 31, 2019 3,353,616        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issuance costs   (15,151)     (15,151)
Common shares issued for services - officers   13,000     13,000
Common shares issued for acquisition of license $ 61 539,356     539,417
Common shares issued for acquisition of license (in shares) 61,297        
Common shares issued for settlement of debt $ 11 99,989     100,000
Common shares issued for settlement of debt (in shares) 11,363        
Refund for fractional stock   (117)     (117)
Stock option expense   155,019     155,019
Net loss for the period     (1,306,361)   (1,306,361)
Foreign currency translation adjustments       16,344 16,344
Balances at Nov. 30, 2019 $ 3,426 11,070,517 (6,117,117) 6,538 4,963,364
Balances (in shares) at Nov. 30, 2019 3,426,276        
Balances at Aug. 31, 2019 $ 3,354 10,278,421 (4,810,756) (9,806) 5,461,213
Balances (in shares) at Aug. 31, 2019 3,353,616        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss for the period         (2,676,487)
Foreign currency translation adjustments         25,763
Balances at Feb. 29, 2020 $ 3,427 11,175,913 (7,487,243) 15,957 3,708,054
Balances (in shares) at Feb. 29, 2020 3,427,399        
Balances at Nov. 30, 2019 $ 3,426 11,070,517 (6,117,117) 6,538 4,963,364
Balances (in shares) at Nov. 30, 2019 3,426,276        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Additional common shares issued $ 7 (7)      
Additional common shares issued (shares) 7,373        
Common shares issued for services - officers   10,500     10,500
Cancellation of common shares $ 6 (2,494)     (2,500)
Cancellation of common shares (shares) (6,250)        
Stock option expense   97,397     97,397
Net loss for the period     (1,370,126)   (1,370,126)
Foreign currency translation adjustments       9,419 9,419
Balances at Feb. 29, 2020 $ 3,427 11,175,913 (7,487,243) 15,957 3,708,054
Balances (in shares) at Feb. 29, 2020 3,427,399        
Balances at Aug. 31, 2020 $ 4,992 13,271,549 (9,465,618) 63,762 $ 3,874,685
Balances (in shares) at Aug. 31, 2020 4,991,587       4,991,587
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common shares issued for cash $ 10,120 6,568,433     $ 6,578,553
Common shares issued for cash (in shares) 10,120,000        
Common shares issued for services - officers   10,500     10,500
Stock option expense   40,868     40,868
Net loss for the period     (1,434,645)   (1,434,645)
Foreign currency translation adjustments       (16,235) (16,235)
Balances at Nov. 30, 2020 $ 15,112 19,891,350 (10,900,263) 47,527 9,053,726
Balances (in shares) at Nov. 30, 2020 15,111,587        
Balances at Aug. 31, 2020 $ 4,992 13,271,549 (9,465,618) 63,762 $ 3,874,685
Balances (in shares) at Aug. 31, 2020 4,991,587       4,991,587
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss for the period         $ (3,300,566)
Foreign currency translation adjustments         (15,862)
Balances at Feb. 28, 2021 $ 22,213 25,551,842 (12,766,184) 47,900 $ 12,855,771
Balances (in shares) at Feb. 28, 2021 22,213,112       22,213,112
Balances at Nov. 30, 2020 $ 15,112 19,891,350 (10,900,263) 47,527 $ 9,053,726
Balances (in shares) at Nov. 30, 2020 15,111,587        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common shares issued for exercise of warrant $ 7,101 5,319,043     5,326,144
Common shares issued for exercise of warrant (in shares) 7,101,525        
Common shares issued for services - officers   10,500     10,500
Stock option expense   330,949     330,949
Net loss for the period     1,865,921   (1,865,921)
Foreign currency translation adjustments       373 373
Balances at Feb. 28, 2021 $ 22,213 $ 25,551,842 $ (12,766,184) $ 47,900 $ 12,855,771
Balances (in shares) at Feb. 28, 2021 22,213,112       22,213,112